BVS vs HBAN · rev $285.3M vs P/E 13, rev $1.56B
Bioventus Inc (BVS) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
BVS currently screens at market cap $495.1M. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the BVS and HBAN stock pages for the full models.
Not investment advice.